Clinical Trial Update: ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DORavirine in adults with HIV experiencing virological failure on first-line efavirenz-based ART with NNRTI resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)

Snippet

Sponsor: Professor Francois Venter | Conditions: HIV-1-infection | Phase 3 | Status: UNKNOWN